Hydralazine_Hydrochloride: profile and news
NitroMed Reports Financial Results for Fourth Quarter and Full ... Mar 2, 2006
Of total revenue, BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) product sales accounted for $3.3 million during the fourth quarter, $4.5 million ... - Genetic Engineering News,
NitroMed to Present at the SG Cowen & Co. Health Care Conference ... Feb 28, 2006
Officer, will present a corporate overview and progress report on the commercial launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) on Monday ... - Genetic Engineering News,
Multimedia News Release - Heart Failure Society Supports the Use ... Feb 23, 2006
This combination is available as a proprietary fixed-dose formulation known as BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), developed and ... - PR Newswire (press release),
NitroMed to Host Fourth Quarter and Year End 2005 Earnings Call ... Feb 22, 2006
Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an orally ... - Genetic Engineering News,
NitroMed to Present at BIO CEO & Investor Conference; February 14 ... Feb 7, 2006
Officer, will present a corporate overview and progress report on the commercial launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) on Tuesday ... - Genetic Engineering News,
NitroMed Announces Sale of Common Stock Jan 25, 2006
...corporate purposes, including the continued commercial launch of NitroMed's first marketed product, BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride). ... - Genetic Engineering News,
NitroMed Sells Stock Jan 25, 2006
...corporate purposes, including the continued commercial launch of NitroMed's first marketed product, BiDil (isosorbide dinitrate/hydralazine hydrochloride). - TheStreet.com
NitroMed $62.5M Placement Supporting Growth Of BiDil Jan 25, 2006
...company intends to use the proceeds for general corporate purposes, including commercializing BiDil (isosorbide dinitrate/hydralazine hydrochloride), which was ... - BioWorld Online (subscription),
Gerald W. Bruce Joins NitroMed as Vice President, Sales Jan 17, 2006
Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an orally ... - Genetic Engineering News,
NitroMed Announces Optimization of BiDil(R) Contract Sales Force Jan 20, 2006
Publicis Selling Solutions has been modified to now staff 144 of the original 195 BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) sales territories. ... - Genetic Engineering News,
NitroMed Promotes Michael Sabolinski, MD to the Position of Chief ... Jan 7, 2006
...and participate in certain key decision making processes relative to the development of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) outside of ... - New Age Media Concepts (press release)
Columbia doctor supports heart medication that is aimed at blacks Dec 11, 2005
...some doctors have used a generic version of BiDil with some patients — prescribing the two separate drugs, isosorbide dinitrate and hydralazine hydrochloride ... - The State,
Burrell Named Consumer Agency of Record for NitroMed; Account ... Nov 27, 2005
...services to increase brand awareness and patient education in support of the company's launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride). ... - dBusinessNews Chicago (press release),
BiDil(R) Data to be Presented at American Heart Association ... Nov 11, 2005
...an aldosterone antagonist. BiDil is a fixed-dose combination of isosorbide dinitrate and hydralazine hydrochloride. While the exact ... - Business Wire (press release),
Researchers Seek to Determine Whether Genetic Variations May ... Sep 21, 2005
...influencing cellular levels of nitric oxide (NO) production affect a patient's clinical response to BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride). ... - Genetic Engineering News,
NitroMed Presents BiDil(R) Data on Reverse Remodeling in Heart ... Sep 21, 2005
...was co-sponsored by NitroMed and the Association of Black Cardiologists, suggest that BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) can inhibit ... - Business Wire (press release),
Barbeau Pharma Appoints Charles N. Blitzer President & CEO ... Oct 3, 2005
...lead development drug, BPI-103, is a proprietary reformulated highly pure and stable intravenous form of the hypertensive agent hydralazine hydrochloride. ... - Genetic Engineering News,
Welton O'Neal, Jr., Pharm.D. Joins NitroMed as Vice President ... Sep 12, 2005
Pharm.D., has joined the company as Vice President Medical Affairs, a position to support the launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - Business Wire (press release),
NitroMed to Present at UBS Global Life Sciences Conference ... Sep 20, 2005
Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an orally ... - PharmaLive.com (press release),
NitroMed to Present at Bear Stearns' Healthcare Conference ... Sep 7, 2005
Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an orally ... - Business Wire (press release),
INDIVIDUALIZED MEDICINES OFFER HOPE FOR NARROWING HEALTH ... Sep 2, 2005
The same combination of drugs that are the components of BiDil -- isosorbide dinitrate and hydralazine hydrochloride – was used in at-large population trials ... - Eurweb.com,
Use of BiDil(R) Supported in Updated Heart Failure Guidelines Aug 17, 2005
...dinitrate and hydralazine, now available as a proprietary fixed-dose formulation known as BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), as an ... - PR Newswire (press release),
NitroMed, Inc. Reports Financial Results for Second Quarter 2005 ... Aug 4, 2005
...(NASDAQ: NTMD) a developer of nitric oxide enhancing medicines, including BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), today reported financial ... - Forbes
NitroMed to Host BiDil Launch Overview Analyst Day and Webcast ... Jul 14, 2005
BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) was recently approved by the FDA for the treatment of heart failure in black patients and launched by ... - Business Wire (press release)
Medication for blacks only Jul 29, 2005
BiDil is made from two inexpensive generic drugs, hydralazine hydrochloride and isosorbide dinitrate, long used to dilate blood vessels, hence the name BiDil. ... - Philadelphia Inquirer
Some urge a warning on heart drug for blacks Jul 12, 2005
But one of its two key ingredients, a generic compound known as hydralazine hydrochloride, has been known for a long time to cause lupus in some patients ... - Newsday
Drug could help black patients Jul 17, 2005
BiDil, produced by NitroMed, is a combination of isosorbide dinitrate and hydralazine hydrochloride - drugs that have been prescribed for the treatment of ... - Hattiesburg American
<**results**>
NitroMed Announces Launch of BiDil(R) for the Treatment of Heart ... Jul 1, 2005
...(NASDAQ:NTMD) announced today that BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black ... - Business Wire (press release)
NitroMed have launched BiDil for the treatment of heart failure in ... Jul 3, 2005
NitroMed, Inc. announced today that BiDil? (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black ... - News-Medical.net
Heart failure, FDA approves BiDil in black patients Jun 25, 2005
FDA ( Food and Drug Administration ) approved BiDil ( Isosorbide dinitrate/Hydralazine hydrochloride ) for the treatment of heart failure in black patients. ... - Xagena.it
FDA Approves BiDil(R) for Treatment of Heart Failure in Black ... Jun 23, 2005
...(Nasdaq: NTMD - News) announced today that the US Food and Drug Administration (FDA) approved BiDil® (isosorbide dinitrate/hydralazine hydrochloride) for the ... - Yahoo News (press release)
FDA Approves BiDil for Treatment of Heart Failure in Black ... Jun 24, 2005
...announced today that the US Food and Drug Administration (FDA) approved BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) for the treatment of heart ... - PharmaLive.com (press release)
Heart Drug for Blacks May Increase Lupus Risk Jul 1, 2005
But one of its two key ingredients, a generic compound known as hydralazine hydrochloride, long has been known to cause lupus in some patients, according to ... - Los Angeles Times
Heart drug for Blacks may stimulate lupus Jul 2, 2005
Still, one of its two key ingredients, a generic compound known as hydralazine hydrochloride, long has been known to cause lupus in some patients, according to ... - AZ Central.com
FDA Advisory Committee Recommends Approval for NitroMed’s BiDil ... Jun 16, 2005
...and Renal Drugs Advisory Committee voted to recommend approval of its product candidate BiDil(R)(isosorbide dinitrate/hydralazine hydrochloride) for the ... - mysan.de (Pressemitteilung)
FDA Okays BiDil to Treat Heart Failure in Blacks Jun 24, 2005
BiDil (isosorbide dinitrate/hydralazine hydrochloride) is indicated as an adjunct to current standard heart-failure therapy in self-identified black patients ... - Daily News Central
FDA approves BiDil, first approved drug targeted at a certain race Jun 24, 2005
...announced that the US Food and Drug Administration (FDA) approved BiDil (isosorbide dinitrate/hydralazine hydrochloride) for the treatment of heart failure in ... - Honeycomb Connect
NitroMed Announces Conference Call to Discuss Approval of BiDil ... Jun 27, 2005
NTMD) announced today that it will hold a conference call to discuss the June 23rd approval of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) by the ... - PharmaLive.com (press release)
US Approves First Drug For Specific Racial Group Jun 24, 2005
...in a prepared statement. BiDil is a fixed-dose combination of isosorbide dinitrate and hydralazine hydrochloride. While the exact ... - Halifax Live,
